Investigators identify a metabolic weak point in exhausted immune cells in head and neck cancer
Immune cells can reach head and neck tumors, but once there, many stop functioning. This helps explain why immunotherapy with immune checkpoint inhibitors—which have transformed treatment for some cancers—benefits only 17%–23% ...
Sep 30, 2026
0
4









